Emergent BioSolutions Inc. (FRA:ER4)

Germany · Delayed Price · Currency is EUR

9.19

+0.12 (1.32%)

Last updated: Feb 20, 2026, 3:58 PM CET

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Commercial Products	398.90M	497.30M	386.60M	438.00M	-
Commercial Products Growth	-19.79%	28.63%	-11.74%	-	-
Mcm Products	509.80M	447.20M	579.60M	585.90M	-
Mcm Products Growth	14.00%	-22.84%	-1.08%	-	-
Services	104.90M	78.50M	109.90M	615.50M	472.40M
Services Growth	33.63%	-28.57%	-82.14%	30.29%	-
Unallocated Contracts and Grants	30.00M	26.30M	41.40M	134.20M	115.10M
Unallocated Contracts and Grants Growth	14.07%	-36.47%	-69.15%	16.59%	-
Products	-	-	-	-	989.80M
Total	1.04B	1.05B	1.12B	1.77B	1.58B
Total Growth	-0.54%	-6.10%	-36.99%	12.45%	42.61%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
United States	822.60M	607.20M	886.10M	1.62B	1.47B
United States Growth	35.47%	-31.48%	-45.42%	10.59%	47.47%
Canada	140.40M	224.20M	148.60M	66.70M	46.00M
Canada Growth	-37.38%	50.87%	122.79%	45.00%	-
Other	80.60M	217.90M	82.80M	83.50M	63.40M
Other Growth	-63.01%	163.16%	-0.84%	31.70%	-
Total	1.04B	1.05B	1.12B	1.77B	1.58B
Total Growth	-0.54%	-6.10%	-36.99%	12.45%	42.61%

Source: S&P Global Market Intelligence.